Imatinib-Induced Tremor in a Patient with Chronic Myeloid Leukemia in Chronic Phase

Imatinib-Induced Tremor in a Patient with Chronic Myeloid Leukemia in Chronic Phase

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by three phases: chronic, accelerated, and blast phase. However; first- and second-generation tyrosine kinase inhibitors are used for the treatment of CML with common and uncommon adverse events. Here, we report a 24-year-...

Full description

Bibliographic Details
Main Authors: Khaldun Obeidat, Arwa Alsaud, Amr Ashour, Bahjat Azrieh, Mohammad Abu-Tineh, Shehab Fareed Mohamed, Mohamed A. Yassin
Format: Article
Language:English
Published: Karger Publishers 2019-12-01
Series:Case Reports in Oncology
Subjects:
chronic myeloid leukemia
imatinib
side effects
tremor
tyrosine kinases
Online Access:https://www.karger.com/Article/FullText/504937
id doaj-083d333feee34c5797bc1e93cb1f659e
record_format Article
spelling doaj-083d333feee34c5797bc1e93cb1f659e2020-11-25T00:32:50ZengKarger PublishersCase Reports in Oncology1662-65752019-12-0112391391710.1159/000504937504937Imatinib-Induced Tremor in a Patient with Chronic Myeloid Leukemia in Chronic PhaseKhaldun ObeidatArwa AlsaudAmr AshourBahjat AzriehMohammad Abu-TinehShehab Fareed MohamedMohamed A. YassinChronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by three phases: chronic, accelerated, and blast phase. However; first- and second-generation tyrosine kinase inhibitors are used for the treatment of CML with common and uncommon adverse events. Here, we report a 24-year-old male with CML in chronic phase started on imatinib as upfront medication who developed tremor and recovered spontenously after 3 years.https://www.karger.com/Article/FullText/504937chronic myeloid leukemiaimatinibside effectstremortyrosine kinases
collection DOAJ
language English
format Article
sources DOAJ
author Khaldun Obeidat
Arwa Alsaud
Amr Ashour
Bahjat Azrieh
Mohammad Abu-Tineh
Shehab Fareed Mohamed
Mohamed A. Yassin
spellingShingle Khaldun Obeidat
Arwa Alsaud
Amr Ashour
Bahjat Azrieh
Mohammad Abu-Tineh
Shehab Fareed Mohamed
Mohamed A. Yassin
Imatinib-Induced Tremor in a Patient with Chronic Myeloid Leukemia in Chronic Phase
Case Reports in Oncology
chronic myeloid leukemia
imatinib
side effects
tremor
tyrosine kinases
author_facet Khaldun Obeidat
Arwa Alsaud
Amr Ashour
Bahjat Azrieh
Mohammad Abu-Tineh
Shehab Fareed Mohamed
Mohamed A. Yassin
author_sort Khaldun Obeidat
title Imatinib-Induced Tremor in a Patient with Chronic Myeloid Leukemia in Chronic Phase
title_short Imatinib-Induced Tremor in a Patient with Chronic Myeloid Leukemia in Chronic Phase
title_full Imatinib-Induced Tremor in a Patient with Chronic Myeloid Leukemia in Chronic Phase
title_fullStr Imatinib-Induced Tremor in a Patient with Chronic Myeloid Leukemia in Chronic Phase
title_full_unstemmed Imatinib-Induced Tremor in a Patient with Chronic Myeloid Leukemia in Chronic Phase
title_sort imatinib-induced tremor in a patient with chronic myeloid leukemia in chronic phase
publisher Karger Publishers
series Case Reports in Oncology
issn 1662-6575
publishDate 2019-12-01
description Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by three phases: chronic, accelerated, and blast phase. However; first- and second-generation tyrosine kinase inhibitors are used for the treatment of CML with common and uncommon adverse events. Here, we report a 24-year-old male with CML in chronic phase started on imatinib as upfront medication who developed tremor and recovered spontenously after 3 years.
topic chronic myeloid leukemia
imatinib
side effects
tremor
tyrosine kinases
url https://www.karger.com/Article/FullText/504937
work_keys_str_mv AT khaldunobeidat imatinibinducedtremorinapatientwithchronicmyeloidleukemiainchronicphase
AT arwaalsaud imatinibinducedtremorinapatientwithchronicmyeloidleukemiainchronicphase
AT amrashour imatinibinducedtremorinapatientwithchronicmyeloidleukemiainchronicphase
AT bahjatazrieh imatinibinducedtremorinapatientwithchronicmyeloidleukemiainchronicphase
AT mohammadabutineh imatinibinducedtremorinapatientwithchronicmyeloidleukemiainchronicphase
AT shehabfareedmohamed imatinibinducedtremorinapatientwithchronicmyeloidleukemiainchronicphase
AT mohamedayassin imatinibinducedtremorinapatientwithchronicmyeloidleukemiainchronicphase
_version_ 1725318878405328896

Similar Items